Serum Ghrelin in Polycystic Ovary Syndrome

Polycystic Ovary Clinical Trial

Official title:

Ghrelin in Polycystic Ovary Syndrome

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02087410
• Other study ID #: Ghrelin
• Status: Not yet recruiting
• Phase: N/A
• First received: March 12, 2014
• Last updated: March 13, 2014
• Start date: April 2014
• Est. completion date: December 2014

Study information

• Verified date: March 2014
• Source: Ain Shams University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Egypt: Ministry of Higher Education
• Study type: Observational

Clinical Trial Summary

measuring serum gherlin in polycystic ovary syndrome patients and compare it to healthy levels

Description:

two groups one healthy and other with pco measure ghrelin level in both of them to find relation between pco and ghrelin

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 84
• Est. completion date: December 2014
• Est. primary completion date: October 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 35 Years

Eligibility

Inclusion Criteria:pco women

• At least 12 months of infertility.

• Patients with polycystic ovarian syndrome according to Rotterdam criteria:

Exclusion Criteria:

• Patients with hyperprolactinemia

• Patients with Cushing's syndrome

• Patients with Congenital or non-classical adrenal hyperplasia

• Patients with hormone secreting tumors.

• Patients with hormonal treatment in the last 3 months.

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Polycystic Ovary
• Polycystic Ovary Syndrome

Locations

Country	Name	City	State
Egypt	Maternity Hospital	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
amr hesham el etreby

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	relationships between circulating ghrelin and the clinical and biochemical manifestations of PCOS	Analysis of levels of ghrelin in study group	after 6 monthes	No